Bio-Techne Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	2018 - 1995
Net Income	203	285.26	272.05	140.41	229.3	96.07	Upgrade
Depreciation & Amortization	110.58	107.24	101.07	87.75	82.74	78.17	Upgrade
Share-Based Compensation	28.89	39.23	42.18	48.98	32.37	32.28	Upgrade
Other Operating Activities	-35.59	-177.34	-90.03	75.03	-139.18	-24.9	Upgrade
Operating Cash Flow	306.88	254.39	325.27	352.16	205.22	181.62	Upgrade
Operating Cash Flow Growth	12.12%	-21.79%	-7.64%	71.61%	12.99%	6.60%	Upgrade
Capital Expenditures	-55.73	-38.24	-44.91	-44.3	-51.74	-25.41	Upgrade
Acquisitions	-167.56	-242.14	0	-225.91	1.91	-289.49	Upgrade
Change in Investments	24.31	14.74	-51.94	26.69	76.93	-21.9	Upgrade
Investing Cash Flow	-198.98	-265.65	-96.85	-243.52	27.1	-336.8	Upgrade
Dividends Paid	-50.39	-50.29	-50.19	-49.62	-48.9	-48.36	Upgrade
Share Issuance / Repurchase	-33.63	10.25	-83.8	21.91	20.87	22.55	Upgrade
Debt Issued / Paid	19	94	-85.5	-15.5	-148.5	166.5	Upgrade
Other Financing Activities	-21.51	-31.35	-23.37	-19.34	-7.27	-6.3	Upgrade
Financing Cash Flow	-86.53	22.62	-242.85	-62.55	-183.8	134.38	Upgrade
Exchange Rate Effect	-8.74	-3.36	-12.09	6.37	-2.77	-0.31	Upgrade
Net Cash Flow	12.63	8	-26.52	52.47	45.74	-21.1	Upgrade
Free Cash Flow	251.15	216.15	280.36	307.86	153.47	156.21	Upgrade
Free Cash Flow Growth	7.91%	-22.90%	-8.93%	100.60%	-1.75%	4.53%	Upgrade
Free Cash Flow Margin	21.76%	19.02%	25.36%	33.07%	20.78%	21.88%	Upgrade
Free Cash Flow Per Share	1.60	1.38	1.79	1.99	1.00	1.03	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).